FCGR1A and COVID-19: This study aims to investigate the activation of blood neutrophils and monocytes from COVID-19 patients by determining the expression of receptors for IgG (CD64), adhesion molecules (CD11b, CD162, CD65s, CD15s), and cell activation (CD66b), and evaluating whether they can be potential markers of inflammation in severe COVID19, especially in the context of hospital-acquired bacterial superinfection and to clinical prognosis assessment.